The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: Direct survey among health professionals

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 12, 2011, Pages 1295-1302

  Pérez García, Mariley ^a   Figueras, Albert ^b  

^a Knop Laboratories   (Chile)

^b Fundacion Institut Catala de Farmacologia   (Spain)

Author keywords

Latin America; Pharmacovigilance; Underreporting; Venezuela; Voluntary reporting

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; HEALTH PRACTITIONER; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PHARMACIST; PRIORITY JOURNAL; QUESTIONNAIRE; VENEZUELA; VOLUNTARY REPORTING;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PHARMACISTS; PHARMACOVIGILANCE; PHYSICIANS; QUESTIONNAIRES; VENEZUELA;

EID: 81955160807     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2193     Document Type: Article

References (16)

1. De Vries TPGM, Henning RH, Hogerzeil HV, et al. Guide to good prescribing - A practical manual. WHO/DAP/94.11. World Health Organization, Geneva, 1994.
2. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 2004; 329: 15-19.
3. Aagaard L, Hansen EH. Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs. BMC Clin Pharmacol 2009; 9: 4.
4. Hazell L, Shakir S. Under-reporting of adverse drug reactions: a systematic review. Rev. Art. Drug Saf 2006; 29: 5.
5. López-González E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf 2009; 32: 19-31.
6. Vallano A, Cereza G, Pedros C, et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol 2005 Dec; 60(6): 653-658.
7. Irujo M, Beitia G, Bes-Rastrollo M, Figueiras A, Hernández-Díaz S, Lasheras B. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf 2007; 30: 1073-1082.
8. Hasford J, Goettler M, Munter KH, Mller-Oerlinghausen B. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. Clin Epidemiol 2002; 55: 945-950.
9. Herdeiro MT, Figueiras A, Polnia J, Gestal-Otero JJ. Influence of pharmacists' attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2006; 29(4): 331-340.
10. Aziz Z, Siang TC, Badarudin NS. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiol Drug Saf 2007; 16: 223-228.
11. Debesa F, Jiménez G, Figueras A, et al. Spontaneous reporting of adverse drug reactions in Cuba: integrating continuous education, training and research in a network approach. Br J Clin Pharmacol 2002; 54: 335-336.
12. Li Q, Zhang SM, Chen HT, et al. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J (Engl). 2004 Jun; 117: 856-861.
13. Belton KJ, Lewis SC, Payne S, et al. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol 1995; 39: 223-226.
14. Herdeiro M, Figueiras A, Polonia J, et al. Physicians's Attitudes and Adverse Drug Reaction Reporting. Drug Saf 2005; 28: 9.
15. Bello SO, Umar MT. Knowledge and attitudes of physicians relating to reporting of adverse drug reactions in Sokoto, north-western Nigeria. Ann Afr Med 2011; 10: 13-18.
16. Belton KJ. European Pharmacovigilance Research Group. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur J Clin Pharmacol 1997; 52: 423-427.